Eddie Joe Sullivan is PRESIDENT of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 5.23 Million shares of SABS, which is worth approximately $20.9 Million. The most recent transaction as insider was on Dec 07, 2023, when has been sold 1,740 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $1,531. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.23M
0% 3M change
0% 12M change
Total Value Held $20.9 Million

Eddie Joe Sullivan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2023
BUY
Open market or private purchase
$1,531 $0.88 p/Share
1,740 Added 0.03%
5,232,304 Common Stock
Sep 07 2022
BUY
Open market or private purchase
$10,360 $0.74 p/Share
14,000 Added 0.27%
5,230,564 Common Stock
Oct 22 2021
BUY
Grant, award, or other acquisition
-
5,213,764 Added 50.0%
5,213,764 Common Stock
Oct 07 2021
BUY
Grant, award, or other acquisition
$28,196 $10.07 p/Share
2,800 Added 50.0%
2,800 Common Stock
EJS

Eddie Joe Sullivan

PRESIDENT
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Track Activities on SABS